Autonomix Medical Presents Top Abstract at CRT 2026, Showcasing Clinical Feasibility and Outcomes of Novel Peripheral RF Nerve Neurolysis Technique.

Autonomix Medical was selected for a podium presentation at CRT 2026, highlighting clinical feasibility and outcomes of a novel technique for transvascular peripheral RF nerve neurolysis. The presentation will be given by Nikola Cesarovic, PhD, and focuses on a novel RF-based approach designed to selectively disrupt peripheral nerve activity via a transvascular approach. The selection underscores the growing clinical interest in precision nerve-targeted therapies and highlights the potential of Autonomix's platform to enable controlled, transvascular peripheral nerve modulation.